The Asia Pacific vaccine market was valued at USD 4.56 billion in 2024, driven by increasing incidence of infectious diseases, innovations in vaccine technology, and expanding immunization programs. The market is projected to grow at a CAGR of 7.80% between 2025 and 2034, reaching nearly USD 9.66 billion by 2034. https://www.expertmarketresearch.com/reports/asia-pacific-vaccine-market